Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014
Scott E. Hadland, J. Frank Wharam, Mark A. Schuster, et al.
JAMA Pediatrics (2017) Vol. 171, Iss. 8, pp. 747-747
Open Access | Times Cited: 251

Showing 1-25 of 251 citing articles:

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
Sarah E. Wakeman, Marc R. Larochelle, Omid Ameli, et al.
JAMA Network Open (2020) Vol. 3, Iss. 2, pp. e1920622-e1920622
Open Access | Times Cited: 717
Management of opioid use disorder in the USA: present status and future directions
Carlos Blanco, Nora D. Volkow
The Lancet (2019) Vol. 393, Iss. 10182, pp. 1760-1772
Closed Access | Times Cited: 337
Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study
Joel D. Hudgins, John J. Porter, Michael C. Monuteaux, et al.
PLoS Medicine (2019) Vol. 16, Iss. 11, pp. e1002922-e1002922
Open Access | Times Cited: 191
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees
Hillary Samples, Arthur Robin Williams, Mark Olfson, et al.
Journal of Substance Abuse Treatment (2018) Vol. 95, pp. 9-17
Open Access | Times Cited: 182
Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder
Scott E. Hadland, Sarah M. Bagley, Jonathan Rodean, et al.
JAMA Pediatrics (2018) Vol. 172, Iss. 11, pp. 1029-1029
Open Access | Times Cited: 174
Patient-Reported Experiences of Discrimination in the US Health Care System
Paige Nong, Minakshi Raj, Melissa S. Creary, et al.
JAMA Network Open (2020) Vol. 3, Iss. 12, pp. e2029650-e2029650
Open Access | Times Cited: 159
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019
Pia M. Mauro, Sarah Gutkind, Erin Annunziato, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e223821-e223821
Open Access | Times Cited: 152
What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
Katherine M. Keyes, Caroline Rutherford, Ava Hamilton, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 3, pp. 100052-100052
Open Access | Times Cited: 148
Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities
Ramin Mojtabai, Christine Mauro, Melanie M. Wall, et al.
Health Affairs (2019) Vol. 38, Iss. 1, pp. 14-23
Open Access | Times Cited: 143
Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity
Gitanjali Srivastava, Claudia K. Fox, Aaron S. Kelly, et al.
Obesity (2019) Vol. 27, Iss. 2, pp. 190-204
Open Access | Times Cited: 112
Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
Austin S. Kilaru, Ruiying Xiong, Margaret Lowenstein, et al.
JAMA Network Open (2020) Vol. 3, Iss. 5, pp. e205852-e205852
Open Access | Times Cited: 110
Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults
Rachel Alinsky, Bonnie T. Zima, Jonathan Rodean, et al.
JAMA Pediatrics (2020) Vol. 174, Iss. 3, pp. e195183-e195183
Open Access | Times Cited: 84
Substance Use Among College Students
Justine W. Welsh, Yujia Shentu, Dana B. Sarvey
FOCUS The Journal of Lifelong Learning in Psychiatry (2019) Vol. 17, Iss. 2, pp. 117-127
Open Access | Times Cited: 76
The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada
Micah Piske, Haoxuan Zhou, Jeong Eun Min, et al.
Addiction (2020) Vol. 115, Iss. 8, pp. 1482-1493
Open Access | Times Cited: 74
Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment
O. Hall, Ayana Jordan, Julie Teater, et al.
Journal of Substance Abuse Treatment (2021) Vol. 133, pp. 108551-108551
Closed Access | Times Cited: 66
Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use
Mara A.G. Hollander, Chung‐Chou H. Chang, Antoine Douaihy, et al.
Drug and Alcohol Dependence (2021) Vol. 227, pp. 108927-108927
Open Access | Times Cited: 64
Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities
Aaron Hogue, Sara J. Becker, Kevin Wenzel, et al.
Journal of Substance Abuse Treatment (2021) Vol. 129, pp. 108402-108402
Open Access | Times Cited: 56
History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
Christian Heidbreder, Paul J. Fudala, Mark K. Greenwald
Drug and Alcohol Dependence Reports (2023) Vol. 6, pp. 100133-100133
Open Access | Times Cited: 29
Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS
Donald E. Greydanus, Ahsan Nazeer, Dilip R. Patel
Disease-a-Month (2025), pp. 101853-101853
Closed Access | Times Cited: 1
Stigma associated with medication treatment for young adults with opioid use disorder: a case series
Scott E. Hadland, Tae Woo Park, Sarah M. Bagley
Addiction Science & Clinical Practice (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 80
Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity
Michael S. Toce, Peter R. Chai, Michele M. Burns, et al.
Journal of Medical Toxicology (2018) Vol. 14, Iss. 4, pp. 306-322
Open Access | Times Cited: 76
Youth and the Opioid Epidemic
Sharon Levy
PEDIATRICS (2019) Vol. 143, Iss. 2
Open Access | Times Cited: 69
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others
Mark Olfson, Victoria Zhang, Michael Schoenbaum, et al.
Health Affairs (2020) Vol. 39, Iss. 6, pp. 984-992
Open Access | Times Cited: 58
Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time
Keri N. Althoff, Kathryn M. Leifheit, Ju Nyeong Park, et al.
Drug and Alcohol Dependence (2020) Vol. 216, pp. 108321-108321
Open Access | Times Cited: 54
Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US
Gerald J. Stahler, Jeremy Mennis, David Baron
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108849-108849
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top